메뉴 건너뛰기




Volumn 25, Issue 3, 1998, Pages 215-223

Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT(1A) receptor radioligand, [carbonyl-11C]WAY- 100635 - Explanation of high signal contrast in PET and an aid to biomathematical modelling

Author keywords

5 HT(1A) receptor; carbonyl 11C WAY 100635; Antagonist; Human brain; PET; Radioactive metabolites

Indexed keywords

CARBON 11; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN 1A AGONIST; SEROTONIN 1A RECEPTOR;

EID: 0032053627     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(97)00206-0     Document Type: Article
Times cited : (90)

References (29)
  • 1
    • 0025944364 scopus 로고
    • 1A binding in rat brain - A combined in situ hybridisation/in vitro receptor autoradiographic study
    • 1A binding in rat brain - A combined in situ hybridisation/in vitro receptor autoradiographic study. Brain Res. 561, 51-60.
    • (1991) Brain Res. , vol.561 , pp. 51-60
    • Chalmers, D.T.1    Watson, S.J.2
  • 7
    • 0002291141 scopus 로고
    • Radioligand disposition and metabolism - Key information in early drug development
    • Edited by Comar D. Kluwer, Dordrecht, The Netherlands
    • 7. Halldin C., Swahn C.-G., Farde L. and Sedvall G. (1995) Radioligand disposition and metabolism - key information in early drug development. In: PET for Drug Development and Evaluation (Edited by Comar D.), pp. 55-65. Kluwer, Dordrecht, The Netherlands.
    • (1995) PET for Drug Development and Evaluation , pp. 55-65
    • Halldin, C.1    Swahn, C.-G.2    Farde, L.3    Sedvall, G.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.